Formulation, Characterization, and Potential Therapeutic Implications of Encapsulated Recombinant Alpha-luffin in Niosomes
These findings suggest that niosomes loaded with LUF hold promise as a potential treatment strategy for breast cancer.
Authors
- Fariba Esmaeili (ORCID: https://orcid.org/0000-0003-2936-5890)
- Leila Nematollahi (ORCID: https://orcid.org/0000-0002-5245-8764)
- Farzaneh Barkhordari (ORCID: https://orcid.org/0000-0003-0836-6712)
- Babak Negahdari (ORCID: https://orcid.org/0000-0002-8742-9138)
- Behnaz Landi (ORCID: https://orcid.org/0000-0001-8265-2579)
- Elham Bayat (ORCID: https://orcid.org/0000-0003-0502-7870)
- Somayeh Sadeghi (ORCID: https://orcid.org/0000-0003-3012-2781)
- Hajar Abedi Joni
- Yeganeh Talebkhan
- Haleh Bakhshandeh
Institutions
- Pasteur Institute of Iran (IR)
- Biotechnology Research Center (IR)
- Tehran University of Medical Sciences (IR)
Publication Details
- Journal
- Current Pharmaceutical Biotechnology
- Published
- 2024-08-26
- DOI
- https://doi.org/10.2174/0113892010316435240806053230
- Primary Topic
- Advancements in Transdermal Drug Delivery
- Type
- article
- Field-Weighted Citation Impact
- 0.00